To scroll text in this page

Global Navigation
Global Navigation end

About Astellas

Start of the main text

2012 News Releases

About RSS

Global News

Medivation and Astellas Announce XTANDI® (enzalutamide) is Now Available for PatientsWith Metastatic Castration-Resistant Prostate Cancer Previously Treated with Docetaxel (pdf 68KB)

September 14, 2012

Printer-friendly version


Main Text end
Local Navigation
Local Navigation end
Related Links